Sign in to view content

Long-Term Efficacy and Safety of the Port Delivery System With Ranibizumab in Patients With nAMD: Results of the Portal 5-year Subgroup Analysis

David J Massop, MD

Video
Published 2023

Related

Baseline DR Severity and Time to DME Resolution in Patients Treated With Ranibizumab in the RIDE and RISE Clinical Trials
Katherine E Talcott, MD
Annual Meeting Talks
2021
Fluorescein Angiographic Evaluation of Peripheral Retinal Vasculature After Ranubizumab Injection for Type I Retinopathy of Prematurity
Clio Armitage Harper, MD
Annual Meeting Talks
2016
The Impact of the COVID-19 Pandemic on Aflibercept and Ranibizumab Anti-VEGF Injections
Kapil Mishra, MD
On Demand Cases, Courses, and Papers
2021

Category: AMD-Neovascular

See more